EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia.

Saved in:
Bibliographic Details
Title: EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia.
Authors: van Steenbergen HW; Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands., Doornkamp F; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, the Netherlands., Alivernini S; Division of Rheumatology, Fondazione Policlinico Universitário A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico-Università Cattolica del Sacro Cuore, Rome, Italy., Backlund J; At-risk participant., Codreanu C; Center for Rheumatic Diseases, University of Medicine and Pharmacy, Bucharest, Romania., Cohen SB; University of Texas Southwestern Medical School, Dallas, TX, USA., Combe B; Montpellier University, Montpellier, France., Cope AP; Centre for Rheumatic Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK., Deane KD; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., England BR; Veterans Affairs Nebraska-Western Iowa Health Care System & University of Nebraska Medical Center, Omaha, NE, USA., Falahee M; Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK., de Jong PHP; Department of Rheumatology, Erasmus Medical Centre, Rotterdam, the Netherlands., Kleyer A; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Department of Internal Medicine 3, Rheumatology and Immunology University Hospital Erlangen and Friedrich Alexander University (FAU), Erlangen, Germany., Lacaille D; Arthritis Research Canada, Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Maat B; Patient Research Partner European Alliance of Associations for Rheumatology People with Arthritis and Rheumatism in Europe and National Association ReumaZorg Nederland, the Netherlands., Mankia K; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and National Institute for Health and Care Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals National Health Services Trust, Leeds, UK., van Mulligen E; Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands; Department of Rheumatology, Erasmus Medical Centre, Rotterdam, the Netherlands., Nagy G; Department of Rheumatology and Clinical Immunology, Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary; Heart and Vascular Center, Semmelweis University, Budapest, Hungary; Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary; National Institute of Locomotor Diseases and Disabilities, Budapest, Hungary., O'Neil LJ; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada., Rodamaker L; Department of Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA., Sahbudin I; Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK; National Institute for Health and Care Research Birmingham Biomedical Research Center and Clinical Research Facility, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK., van Schaardenburg D; Amsterdam Rheumatology Center, Reade, Amsterdam, the Netherlands., Sepriano A; Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands; Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal., da Silva JAP; Department of Rheumatology, Centro Hospitalar e Universitário de Coimbra, Institute for Clinical and Biomedical Research, Faculty of Medicine, University of Coimbra, Portugal., De Smet L; Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands., Sparks JA; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Steyerberg EW; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, the Netherlands., Studenic P; Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Vienna, Austria; Department of Medicine (Solna), Division of Rheumatology, Karolinska Institute, Stockholm, Sweden., Wethington E; Patient research partner, Department of Information Services and Technology, National Jewish Health, Denver, CO, USA., Landewé RL; Rheumatology & Clinical Immunology, Amsterdam University Medical Center, Amsterdam, the Netherlands; Department of Rheumatology, Zuyderland Medical Center, Heerlen, the Netherlands., Raza K; Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK; Department of Rheumatology, Bronglais Hospital, Hywel Dda University Health Board, Aberystwyth, UK., van der Helm-van Mil AHM; Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands; Department of Rheumatology, Erasmus Medical Centre, Rotterdam, the Netherlands. Electronic address: a.h.m.van_der_helm@lumc.nl.
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2025 Sep; Vol. 84 (9), pp. 1445-1457. Date of Electronic Publication: 2025 May 08.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-2060
DOI:10.1016/j.ard.2025.01.021